Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
AAPS PharmSciTech ; 22(6): 211, 2021 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-34374899

RESUMEN

This study evaluates the potential use of near-infrared hyperspectral imaging (NIR-HSI) for quantitative determination of the drug amount in inkjet-printed dosage forms. We chose metformin hydrochloride as a model active pharmaceutical ingredient (API) and printed it onto gelatin films using a piezoelectric inkjet printing system. An industry-ready NIR-HSI sensor combined with a motorized movable linear stage was applied for spectral acquisition. Initial API-substrate screening revealed best printing results for gelatin films with TiO2 filling. For calibration of the NIR-HSI system, escalating drug doses were printed on the substrate. After spectral pre-treatments, including standard normal variate (SNV) and Savitzky-Golay filtering for noise reduction and enhancement of spectral features, principal component analysis (PCA) and partial least squares (PLS) regression were applied to create predictive models for the quantification of independent printed metformin hydrochloride samples. It could be shown that the concentration distribution maps provided by the developed HSI models were capable of clustering and predicting the drug dose in the formulations. HSI model prediction showed significant better correlation to the reference (HPLC) compared to on-board monitoring of dispensed volume of the printer. Overall, the results emphasize the capability of NIR-HSI as a fast and non-destructive method for the quantification and quality control of the deposited API in drug-printing applications.


Asunto(s)
Imágenes Hiperespectrales , Espectroscopía Infrarroja Corta , Composición de Medicamentos , Análisis de los Mínimos Cuadrados , Control de Calidad
2.
Drug Discov Today ; 25(4): 800-806, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31982395

RESUMEN

The pharmaceutical industry today is experiencing a paradigm shift from batch to continuous manufacturing, which promises greater flexibility to target diverse populations, as well as more-consistent product quality to ensure best efficacy. However, shifting to continuous processing means that even basic process steps, such as feeding, can become unexpected but are crucially important. In this review, we will present the fundamental differences between dispensing (batch) and feeding (continuous) and how they impact the formulation design space. We will further outline our rational development approach, applicable to continuous unit operations in general, which includes standardized material and process characterization, as well as predictive modeling based on advanced, multidomain simulation tools.


Asunto(s)
Química Farmacéutica/métodos , Industria Farmacéutica/métodos , Tecnología Farmacéutica/métodos , Simulación por Computador , Composición de Medicamentos/métodos , Diseño de Equipo , Humanos , Ciencia de los Materiales , Preparaciones Farmacéuticas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA